This project will support the Climate Adaptation and Resilience (CLARE2) partnership by covering the operational costs (including salaries and benefits), office expenses and travel of project-paid positions required to implement the program.
Despite the rapid development and deployment of artificial intelligence (AI) in low- and lower-middle-income countries to address global health challenges, the limited sharing of lessons learned reduces the chances for success of subsequent innovations.
Artificial intelligence (AI) solutions and data science approaches are increasingly being used to identify risks, conduct predictive modeling and provide evidence-based recommendations for public health policy and action.
The newly released annual report on the Global Partnership for Education (GPE) Knowledge and Innovation Exchange (KIX) shows that the initiative — the largest education fund of its kind — is closing the gap between research innovation and policy impact.
IDRC, the Israel Science Foundation, the Azrieli Foundation and the Canadian Institutes of Health Research (CIHR) are pleased to announce the second research competition under Phase II of the Joint Canada-Israel Health Research Program.
The Canadian Institutes of Health Research (CIHR) and IDRC, on behalf of the Government of Canada, are supporting a rapid research response to outbreaks of Monkeypox in Canada and Africa. The Monkeypox Rapid Research Response competition will launch the week of August 1, 2022.
An IDRC-supported special issue on gender-lens investing was recently published in the Journal of Sustainable Finance and Investment. Gender-lens investing is a growing arm of sustainable finance that considers and measures contributions to gender equality and financial returns.
This project will support Phase II of the Knowledge for Democracy Myanmar (K4DM2) partnership by covering the operational costs of capacity building, including salaries and benefits, office costs and travel of IDRC staff.
Lakes provide essential natural resources for populations in low- and middle-income countries (LMICs), but there is growing concern of contamination with antimicrobial resistant (AMR) determinants from animal and human sources, especially beta-lactams and carbapenems that are the cornerstone of human antimicrobial therapy.
More than half of the world’s population is excluded from opportunities the rule of law provides, and 1.5 billion people cannot access support to resolve justice problems. IDRC supports research on legal empowerment strategies to address this growing justice gap and to promote vibrant civic spaces.
Colistin is considered a last-resort antimicrobial for treatment of infections with multidrug-resistant bacteria, classified by the World Health Organization (WHO) as ‘highest prioritized, critically important for human medicine’.
The Climate Adaptation and Resilience (CLARE) initiative is pleased to announce that its first public call for concept notes will be launched in April 2022. CLARE supports research to enable socially inclusive and sustainable action to build resilience to climate change and natural hazards across Africa and Asia-Pacific.